Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · March 12, 2022

Single-Arm Study of Anamorelin in Patients With Cancer Cachexia and Low BMI

Cancer

 

Additional Info

Cancer
A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in patients with cancer cachexia and low body mass index
Cancer 2022 Feb 23;[EPub Ahead of Print], T Naito, J Uchino, T Kojima, Y Matano, K Minato, K Tanaka, T Mizukami, S Atagi, T Higashiguchi, K Muro, K Takayama, J Furuse, E Morishima, T Takiguchi, K Tamura

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading